The estimated Net Worth of Colin Mc Hugh is at least 210 千$ dollars as of 3 September 2024. Colin Hugh owns over 1,534 units of Accolade stock worth over 210,299$ and over the last few years Colin sold ACCD stock worth over 0$.
Colin has made over 15 trades of the Accolade stock since 2023, according to the Form 4 filled with the SEC. Most recently Colin exercised 1,534 units of ACCD stock worth 5,998$ on 3 September 2024.
The largest trade Colin's ever made was exercising 17,898 units of Accolade stock on 11 June 2024 worth over 69,981$. On average, Colin trades about 2,253 units every 27 days since 2023. As of 3 September 2024 Colin still owns at least 53,785 units of Accolade stock.
You can see the complete history of Colin Hugh stock trades at the bottom of the page.
Colin's mailing address filed with the SEC is C/O ACCOLADE, INC., 1201 3RD AVE, SUITE 1700, SEATTLE, WA, 98101.
Over the last 4 years, insiders at Accolade have traded over 9,006,680$ worth of Accolade stock and bought 74 units worth 743$ . The most active insiders traders include Edgar Jr Bronfman、Jeffrey D Jordan、Dawn G Lepore. On average, Accolade executives and independent directors trade stock every 5 days with the average trade being worth of 18,928$. The most recent stock trade was executed by Rajeev Singh on 3 September 2024, trading 3,786 units of ACCD stock currently worth 14,803$.
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Accolade executives and other stock owners filed with the SEC include: